hit counter

4 Depression Subtypes Identified via PHQ-9 Tool: Affective, Somatic, Internalizing, Sensorimotor (2023 Study)

Depression, a multifaceted mental health disorder affecting millions worldwide, has long been a challenge for both diagnosis and treatment.

The standard method for evaluating depression in outpatient settings, the Patient Health Questionnaire-9 (PHQ-9), has traditionally been viewed as a unidimensional tool.

However, recent research suggests that the complexities of Major Depressive Disorder (MDD) may be better understood through a multidimensional lens.

A new study utilizing factor analysis on the PHQ-9 across large, clinical, and diverse datasets offers new insights into the symptomatology of depression, potentially optimizing the approach to diagnosis and treatment.


  • Novel Approach: A study employed factor analysis on the PHQ-9 without any predefined assumptions, offering a purely data-driven exploration of depression symptoms.
  • Large & Diverse Data: The research leverages three large, clinical, longitudinal datasets, encompassing a wide demographic representative of the U.S. population.
  • Identification of a Parsimonious Model: A four-factor model was identified with excellent fit across datasets, suggesting a more nuanced understanding of depressive symptoms.
  • Potential Impact on Precision Psychiatry: The findings can inform more targeted treatment strategies by categorizing depression into distinct symptom phenotypes.

Source: Psychiatry Research (2023)

Differences in Major Depressive Disorder Symptoms (Overview)

Major Depressive Disorder (MDD) is a complex psychiatric condition characterized by a wide range of symptoms that vary significantly among individuals.

This heterogeneity presents a substantial challenge in understanding, diagnosing, and treating depression effectively.

Identifying subtypes or phenotypes within MDD is critical for several reasons.

Rationale for Research into Subtypes

  • Individual Variability in Symptoms: Patients with MDD can exhibit a diverse array of symptoms, including but not limited to mood disturbances, cognitive impairments, and somatic complaints. This variability suggests underlying differences in the pathology of the disorder.
  • Tailored Treatment Approaches: Understanding these subtypes can lead to more personalized treatment plans. Current treatment strategies are often a ‘one-size-fits-all’ approach, which may not be effective for all patients due to the diverse nature of their symptoms.
  • Improving Diagnostic Accuracy: Accurately diagnosing MDD can be challenging due to its symptom overlap with other psychiatric conditions. Subtyping can aid in more precise diagnosis and avoid misdiagnosis.
  • Better Understanding of Etiology: Researching subtypes can provide insights into the varied causes of depression, including genetic, environmental, and biological factors, thus enhancing our understanding of the disorder.

Classifying Patients into Specific Subtypes

  • Targeted Interventions: Once a patient is classified into a specific subtype, interventions can be more effectively tailored. For instance, a patient primarily exhibiting the ‘somatic’ subtype might benefit more from certain types of medication or therapies focused on bodily symptoms.
  • Predicting Treatment Response: Different subtypes may respond differently to various treatments. Classifying patients can help predict which treatment modalities might be most effective, thus reducing trial and error in treatment selection.
  • Enhanced Patient Care: Understanding a patient’s specific subtype can improve the overall care plan, including non-pharmacological interventions like psychotherapy or lifestyle changes.

The Complexity of Mixed Cases and MDD

  • Combination of Phenotypes: Many patients with MDD may not fit neatly into a single subtype but rather present a mix of symptoms from different subtypes. This complexity further underscores the need for a nuanced approach to diagnosis and treatment.
  • Dynamic Nature of Symptoms: Depression symptoms can vary over time within the same individual. A patient might present different subtypes at different stages of their disorder, adding to the complexity of managing MDD.
  • Comorbid Conditions: The presence of comorbid psychiatric or medical conditions can complicate the symptom profile of MDD, making it challenging to isolate and treat the depressive symptoms effectively.
  • Implications for Research: The mixed and dynamic nature of depression symptoms highlights the need for longitudinal research to track symptom changes over time and understand the evolution of different subtypes within individuals.

PHQ-9 in Depression & Classification of Subtypes (2023 Study)

Tseng et al. conducted a study to analyze Patient Health Questionnaire-9 (PHQ-9) responses to better understand the multifaceted nature of Major Depressive Disorder (MDD).

The study sought to identify whether depressive symptoms, as assessed by the PHQ-9, could be categorized into distinct subfactors that are consistent and stable over time.

This endeavor aimed to challenge the traditional uni-dimensional perception of depression and potentially revolutionize the approach to diagnosis and treatment in clinical psychiatry.


Data Collection: The study analyzed PHQ-9 responses from three separate, large-scale, longitudinal studies. These datasets collectively included 1483 individuals diagnosed with depression, representative of a broad U.S. demographic in terms of sex, age, race, and socio-economic status.

Analytical Approach: Unique to this study, no preconceived assumptions were made about the number of depressive symptom factors or their interrelations. The researchers employed a purely data-driven approach, using both exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). This methodology allowed for the identification of latent structures within the PHQ-9 responses across various timepoints.


Identification of a Four-Factor Model: The study’s major finding was the emergence of a four-factor model that demonstrated excellent fit across the datasets. These factors included:

  1. Affective: Combining symptoms of Anhedonia and Depressed Mood.
  2. Somatic: Encompassing Sleep disturbances, Fatigue, and Appetite changes.
  3. Internalizing: Involving feelings of Worthlessness/Guilt and Suicidality.
  4. Sensorimotor: Relating to problems with Concentration and Psychomotor changes.

This model suggests a more complex and multidimensional structure of depression than previously understood.


  • Self-Reported Data: One significant limitation of the study is the reliance on self-reported data, which may be subject to biases or inaccuracies.
  • Recruitment Methods: The participants were recruited primarily through online platforms and compensated for their participation, which could introduce selection bias.
  • Lack of Clinical Verification: The study did not include clinician-verified diagnoses of depression, relying solely on PHQ-9 scores.
  • Potential Biases: Given the online recruitment and paid participation, the sample may not be entirely representative of the general population with depression.
  • Unexplored Variables: The study did not extensively explore the relationship of the depressive subfactors with other demographic or clinical variables such as gender, race, or comorbid conditions.

Details of Results: 4 Depression Subtypes Identified (PHQ-9)

The study’s results provided significant insights into the heterogeneity of Major Depressive Disorder (MDD) through a detailed analysis of PHQ-9 responses.

1. Affective Subtype

This subtype encompasses anhedonia (loss of interest or pleasure) and depressed mood, highlighting the emotional and mood-related aspects of depression.

These symptoms are central to the classic presentation of depression and are often the most recognizable.

2. Somatic Subtype

This category includes symptoms related to bodily functions such as sleep disturbances, changes in appetite, and fatigue.

These symptoms are particularly relevant in understanding how depression manifests physically, often overlooked in traditional depression assessments.

3. Internalizing Subtype

This subtype comprises feelings of worthlessness or excessive guilt, coupled with suicidality.

It underscores the internalized nature of these symptoms, reflecting a deep sense of self-deprecation and an increased risk of self-harm.

4. Sensorimotor Subtype

This group involves concentration difficulties and changes in psychomotor activity (either agitation or retardation).

These symptoms highlight the cognitive and physical activity changes that can be experienced in depression.

Consistency & Stability Over Time

One of the study’s most critical findings was the stability of these subtypes over time.

This consistency suggests that these subtypes are not transient features but rather stable characteristics of depressive presentations in individuals.

Variability Across Individuals

The study also noted significant variability across individuals regarding which subtypes were most prominent.

This finding reinforces the idea that depression is a highly individualized disorder, with symptom profiles varying significantly from one person to another.

Potential Clinical Applications of the Findings (PHQ-9 Depression Subtypes)

Personalized Treatment Strategies

  • Tailoring Treatment: Understanding a patient’s specific subtype can guide clinicians in selecting the most appropriate treatment, whether pharmacological, psychotherapeutic, or a combination thereof. For example, patients with a predominant somatic subtype might benefit more from treatments targeting physical symptoms.
  • Predicting Treatment Response: Identifying subtypes could also help predict a patient’s response to certain treatments, potentially reducing the time taken to find an effective treatment.

Enhanced Diagnostic Accuracy

  • Subtype-Specific Screening Tools: Incorporating the knowledge of these subtypes into screening tools could enhance the accuracy of MDD diagnoses, allowing for more nuanced detection of the disorder.
  • Differentiating from Other Disorders: The specificity of subtypes could aid in differentiating MDD from other psychiatric conditions with overlapping symptoms, such as anxiety disorders or bipolar disorder.

Improved Understanding of MDD

  • Insights into Etiology: These subtypes could provide insights into the various underlying causes of depression, which could be biological, psychological, or environmental.
  • Research Directions: Identifying stable subtypes opens new avenues for research, particularly in understanding the biological underpinnings and genetic factors associated with each subtype.

Long-Term Management

  • Monitoring Progress Over Time: By tracking the presence and severity of symptoms in each subtype, clinicians can more effectively monitor a patient’s progress and adjust treatment plans as needed.
  • Predicting Relapse or Recovery: Understanding a patient’s subtype could also help in predicting the likelihood of relapse or recovery, facilitating early interventions when necessary.

Limitations of Major Depression Subtypes & Phenotypes

While the identification of distinct subtypes in Major Depressive Disorder (MDD) offers a nuanced understanding of the disorder, there are several limitations to consider regarding their clinical value.

  • Overlap of Symptoms: The symptoms of depression often overlap significantly between subtypes. This overlap can make it challenging to categorize a patient into a single, distinct subtype, potentially leading to oversimplification of their condition.
  • Dynamic Nature of Depression: Depression symptoms can vary over time in their intensity and presentation. A patient categorized into one subtype at a certain time might exhibit a different subtype later, complicating long-term treatment and management.
  • Subjectivity in Interpretation: The categorization into subtypes can be highly subjective, depending on the clinician’s interpretation of symptoms. This subjectivity may lead to inconsistencies in diagnosis and treatment across different healthcare providers.
  • Potential for Labeling & Stigma: Assigning a patient to a specific subtype may inadvertently lead to labeling. This labeling could influence both the patient’s and the clinician’s perceptions and attitudes toward the illness and treatment.
  • Complexity in Treatment Planning: While subtyping aims to tailor treatment, it could also complicate the decision-making process. Clinicians might struggle to choose appropriate treatment strategies, especially for patients presenting symptoms across multiple subtypes.
  • Resource & Training Constraints: Implementing a subtype-based approach to diagnosis and treatment would require additional resources and training for healthcare professionals, which might not be feasible in all clinical settings.

Takeaway: PHQ-9 Responses & Major Depression Subtypes

The recent study on PHQ-9 responses and the resultant identification of subtypes within Major Depressive Disorder (MDD) marks a significant step forward in understanding this complex condition.

It highlights the multifaceted nature of depression, challenging the traditional unidimensional view and suggesting a more nuanced approach to diagnosis and treatment.

However, the practical application of these subtypes in clinical settings is not without challenges, including symptom overlap, the dynamic nature of the disorder, and potential difficulties in consistent diagnosis and treatment planning.

While these findings open new avenues for personalized treatment strategies, they also underscore the need for cautious implementation, considering the potential for subjectivity and the complexity inherent in mental health diagnoses.

Ultimately, this study contributes valuable insights to the field of psychiatry, paving the way for more research and discussion on how best to incorporate these findings into effective clinical practice for patients with MDD.


Related Posts:

MHD News (100% Free)

* indicates required

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.